CRISPR/cas-related methods and compositions for treating herpes simplex virus
US11390861B2 · kind B2 · utility
0Cited by
8References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 26, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Apr 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/20
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Genome editing systems and genetic constructs that target a herpes simplex virus (HSV) viral gene, where the systems comprise one Cas9 molecule, and a gRNA molecule, compositions and cells comprising such genome editing systems and genetic constructs as well as methods for using the genome editing systems, genetic constructs, compositions and cells for genome engineering, and for preventing, treating or reducing HSV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.